Augment Therapy

About Augment Therapy

Augment Therapy develops immersive augmented reality exercise apps designed for both clinic and home use, aiming to make movement fun and engaging for users of all ages. Their mission focuses on increasing engagement, capturing patient data, and supporting in-person or telehealth sessions, often in partnership with entities like Sesame Workshop to motivate children.

Products & Services

ARWell:A wellness app designed for home use to facilitate exercise and movement.

ARWell PRO:A version of the app tailored for healthcare professionals and their patients, emphasizing professional use in therapy settings.

Specialties

Augmented Reality Exergaming Telehealth Solutions Accessible Technology Physical Therapy Support

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Investment T: - FT: Investment	A: 1000000 MR: - FA: $1 million FAN: 1000000	D: 2023-05-02 FD: 2023-05-02	1 investors

Investment Latest

2023-05-02

$1.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lindsay Watson

PT, MPT

S

Steve Blake

Software Developer

E

Elise Baron

Research Scientist

L

Lisa Blake

Liaison

W

Wayne Brown

C

Carmen Fontana

Top Female Leader in Technology Innovation

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Augment Therapy Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised